Clinical trial
Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons
NCT01010893 is registered in ClinicalTrials.gov with Fluart Innovative Vaccine Ltd, Hungary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tolerability and Immunogenicity Study of FLUVAL P Monovalent Influenza Vaccine in Adults and Elderly Persons
- Lead sponsor
- Fluart Innovative Vaccine Ltd, Hungary
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 31, 2009
- Completion date
- February 28, 2010
- Enrollment
- 355 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
influenza